Literature DB >> 29145730

Screening and evaluation of antioxidant activity of some 1,2,4-triazolo[1,5-a]quinazoline derivatives.

Rashad Al-Salahi1, El-Hassane Anouar2, Mohamed Marzouk2,3, Hanan Aa Taie4, Hatem A Abuelizz1.   

Abstract

AIM: The present study was carried out to assess a new series of triazoloquinazolines 1-40 for their antioxidant activities using 1,1-diphenyl-2-picryl hydrazyl radical scavenging, ferric reduction antioxidant power and reducing power capability assays.
RESULTS: All triazoloquinazolines 1-40 exhibited antioxidant activity ranged from weak to moderate and high. The obtained findings revealed that the triazoloquinazolines 30, 36 and 38-40 have superiority among all compounds, demonstrating the highest capacity to deplete 1,1-diphenyl-2-picryl hydrazyl and free radicals, in relation to butylated hydroxyl toluene, as a synthetic antioxidant agent.
CONCLUSION: Chemical modifications together with density functional theory study on the targets supplied us with some valuable clarifications about the required properties needed for the target compounds to be more active against free radicals.

Entities:  

Keywords:  BHT; DFT; DPPH; FRAP; antioxidant activity; in vitro evaluation; triazoloquinazolines

Mesh:

Substances:

Year:  2017        PMID: 29145730     DOI: 10.4155/fmc-2017-0224

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  2 in total

1.  Experimental and theoretical study on structure-tautomerism among edaravone, isoxazolone, and their heterocycles derivatives as antioxidants.

Authors:  Auriekson N Queiroz; Camila C Martins; Kelton L B Santos; Ederson S Carvalho; Alex O Owiti; Karen R M Oliveira; Anderson M Herculano; Albérico B F da Silva; Rosivaldo S Borges
Journal:  Saudi Pharm J       Date:  2020-06-12       Impact factor: 4.330

Review 2.  Current Trends in Computational Quantum Chemistry Studies on Antioxidant Radical Scavenging Activity.

Authors:  Maciej Spiegel
Journal:  J Chem Inf Model       Date:  2022-04-18       Impact factor: 6.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.